Sort
82,697 grants matching “vaccine development”
Malaria Vaccine: AMA1-C1
$2,113,978Louis Miller · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI
MU-JHU HPTU TRIAL SITE - UGANDA
$2,112,888Johns Hopkins University · U01 · FY2002 · AI
Multiscale Analysis of Immune Responses
$2,112,763Ronald Germain · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
UCLA SPORE in Brain Cancer
$2,112,473Linda M Liau · University Of California Los Angeles · P50 · FY2024 · CA
Impact of Menstruation on Chlamydial and Gonorrhea Infection
$2,112,000Alison Swaims Kohlmeier · Emory University · R01 · FY2025 · AI
Product Development and Manufacture
$2,111,768Robert T McNally · Geovax, Inc. · U19 · FY2011 · AI
VACCINATION AGAINST INTRAPARTUM HIV CLADE C TRANSMISSION
$2,111,611Dana-Farber Cancer Institute · P01 · FY2001 · AI
Broadly Effective HCV Vaccine
$2,111,046Mansun Law · Scripps Research Institute, The · P01 · FY2025 · AI
#4Corners4Health: A Social Media Cancer Prevention Program for Rural Emerging Adults
$2,109,982David B Buller · Klein Buendel, Inc. · R01 · FY2025 · CA
Pacific Center for Emerging Infectious Diseases Research
$2,109,886Richard Yanagihara · University Of Hawaii At Manoa · P20 · FY2012 · GM
Molecular Mechanisms of Pathogenesis of Acute and Chronic Liver Diseases
$2,109,490Patrizia Farci · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Pandemic influenza DNA vaccine Development
$2,109,388Lawrence R Smith · Vical, Inc. · U01 · FY2008 · AI
Environmental/genetic Risk Factors and Pathogenesis of Autoimmune Disease
$2,109,352Frederick Miller · National Institute Of Environmental Health Sciences · ZIA · FY2019 · ES
Meningococcal Immunization Against Gonococcal Infection Clinical Trial
$2,108,870National Institute Of Allergy And Infectious Diseases · Y01 · FY2024 · AI
Tulane National Primate Research Center U24 AIDS SPF Breeding Colony Maintenance
$2,106,828Rudolf P Bohm · Tulane University Of Louisiana · U24 · FY2013 · OD
Vanderbilt HIV Clinical Trials Unit (CTU)
$2,106,727David W Haas · Vanderbilt University Medical Center · UM1 · FY2023 · AI
Protective immunity following dengue virus natural infections and vaccination
$2,106,690Eva Harris · University Of California Berkeley · P01 · FY2015 · AI
Tulane National Primate Research Center, AIDS SPF Breeding Colony Maintenance
$2,106,465Rudolf P Bohm · Tulane University Of Louisiana · U42 · FY2020 · OD
Tulane National Primate Research Center U24 AIDS SPF Breeding Colony Maintenance
$2,106,465Rudolf P Bohm · Tulane University Of Louisiana · U24 · FY2016 · OD
Tulane National Primate Research Center, AIDS SPF Breeding Colony Maintenance
$2,106,465Rudolf P Bohm · Tulane University Of Louisiana · U42 · FY2019 · OD
Tulane National Primate Research Center, AIDS SPF Breeding Colony Maintenance
$2,106,465Rudolf P Bohm · Tulane University Of Louisiana · U42 · FY2017 · OD
Extending Chimeric Antigen (CAR) T cell therapy to thoracic cancers
$2,105,511Steven Mark Albelda · University Of Pennsylvania · P01 · FY2018 · CA
Natural History of HPV Infection in Men: The HIM Study
$2,105,062Anna R Giuliano · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2010 · CA
Immunobiology, molecular virology and countermeasures of highly pathogenic viruses
$2,104,975Andrea Marzi · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
KwaZulu-Natal Clinical Trials Unit
$2,104,487Quarraisha Abdool Karim · Centre/Aids Programme/Res/South Africa · UM1 · FY2023 · AI